Each shareholder's ownership in the firm and proportional voting power remains the same
Niko Kruzel was axed after contacting the BC Budtender Union regarding scheduling, pay and not receiving benefits
Another 7 applications in queue expected to move faster with support, councillor says
Early feedback on the firm's cannabis products has been strong
The sale of items unrelated to cannabis, like snacks or drinks without weed in them, still aren't allowed
The Montreal-based producer will have access to additional cultivation space, more than doubling annual production capacity
TGOD says new acquisitions and marketing partnerships will help boost sales
Private businesses shouldn't have to race to the bottom against public corporations, retailers say
In October, the province started fulfillment and delivery from its distribution centre in St. John's
Company executives say the quarter was important for securing future growth
A subsidiary of Xebra Brands has been challenging prohibition in lower courts for 3 years
The firm's new CEO looks to be off to a strong start
Terry Booth's firm says it's continuing with an 'asset light' approach
The health minister says the country has only a third of the October shipment left and more isn't expected until next month
The letter has no current impact on its listing, company says
Growth was driven by medical cannabis clinic operations in Colombia and Germany, company says
Third-party cannabis delivery isn't yet allowed in the province
The firm is buying 80% of NuLeaf for US$31M
Earlier in November, the company told shareholders it wouldn't be EBITDA-positive in fiscal 2021
The Crown corporation credits its quarterly results to its strategy of beating out the illicit market
Statistics Canada significantly lowered its sales data for August as well
A total 27 million cannabis vape units were sold over the three-month period in both countries, generating over US$900 million in revenue
While many businesses in the region were spared from the worst of the disaster, damaged supply routes will affect most in the inudstry
But other profitability metrics lagged in the quarter
A backburner project slated for years down the line quickly became reality after the province said in August that on-site sales would be allowed
The firm says it had its first EBITDA-profitable month in September
Delays to store openings and 'unforeseen' regulatory issues have caused the firm to rein in its earnings projections for the year
72% of cannabis users say that everyone, or almost everyone, they know consumes cannabis
But net income soared due to a US$69M value gain on warrants
The firm blamed the drop in part on 'seasonal weakness'
Currently only a handful of Canadian nurseries supply genetics to hundreds of licensed pot producers
But concerns remain around its significant debt pile and an inability to pay it off
The firm upped Q3 revenue by 17% but tallied a $13.5M loss
Rose is a third-party supplier for major cannabis companies and micros in Quebec
Particularly the firm's new retail acquisition is turning a profit
The firm is selling in 12 international markets and has added eight more product listings in Canada
The firm is projecting revenues to rise another 9% in Q4
The leading US weed firm continues to post solid growth and fundamentals
The company says a majority of new sales growth is coming from its focus on medical cannabis
Net loss ballooned 507% to US$59 million this fiscal period due to rising expenses






































